Medical Practitioners Tribunal Service determination — review hearing
MPTS extends Dr Kee Pei’s suspension for nine months following review
The tribunal found continuing impairment linked to an overseas regulatory determination and delayed disclosure. It recognised some progress but imposed further suspension with another review.
MedicWatch editorial · Published 7 August 2026 · Updated 21 November 2026
Suspension (suspended from practice) — 9 months
Data last checked: 21 November 2026Report a correction
What does “suspended from practice” mean?
The regulator imposed a fixed-term suspension in this decision. Its start date, appeal provisions and any later review affect whether it is currently in force. Check the official register for the practitioner's current status.
Concerning Kee Pei, doctor (General Medical Council 3505807).
Decision date: 7 August 2026 · Hearing started 7 August 2026
In plain English
The MPTS tribunal extended Dr Kee Pei’s suspension for nine months after finding continuing impairment linked to an overseas regulatory determination and delayed disclosure to the GMC. It recognised relevant study and developing insight, but found insufficient evidence of practical learning, reflection and safeguards against repetition. The tribunal directed another review before expiry. The existing suspension remains in place during the appeal period.
Charges
Review of suspension imposed in July 2025 following a Hong Kong Medical Council determination about inappropriate prescribing to 14 patients and misconduct in failing to notify the GMC without delay of that determination.
Findings
The reviewing tribunal found continuing impairment by reason of both misconduct and a determination by another regulator. It recognised engagement, relevant study and some developing insight, but found insufficient reflection, practical application of learning and safeguards against repetition. It found the risk to public protection remained high. It imposed a further nine-month suspension with a review before expiry. The MPTS will notify the doctor when the new direction takes effect; the existing suspension remains in place during the appeal period. The prescribing and delayed-disclosure findings arose from the previous proceedings, rather than fresh allegations at this review.
Source
All facts on this page are drawn from the publicly published Medical Practitioners Tribunal Service determination linked below. MedicWatch does not editorialise the regulator’s findings.
Spot something incorrect?
If a fact on this page is wrong, or you believe the page should not be published, please submit a correction or takedown request.